Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 100 Million+ Visitors
  • 75000+ Unique visitors per conference
  • 100000+ Page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Recommended Global Medical Ethics & Health Policies Webinars & Conferences

Europe & UK
Asia Pacific & Middle East

HIV Congress 2022

About Conference

Welcome to the Global Submit on HIV-AIDS and STDs and also join the webinar during April 28-29, 2022. HIV Congress 2022 is being organized with the association Journal of HIV-Current Research.

Theme of the webinar highlights “Raising Global Awareness on STD/AIDS and Fighting the Stigma Surrounding the Syndrome Scientific Tracks designed for this webinar will enable the attendees and participants to learn extremes.


• Developing new AIDS medicines

• Antimicrobial resistance in HIV patients

HIV Infection and its Consequences

• HIV Aging and Its Health Problems

Why to Attend:

HIV and AIDS, as well as HIV testing, must be taught and learned about in order to prevent, treat, and care for HIV and AIDS. Informal, interpersonal communication about HIV and AIDS has been demonstrated to affect HIV awareness and stigma, as well as potentially risk behaviours.

Target Audience:

  • This webinar was available to nurses, other health professionals, and students who wanted to learn more about HIV.
  • Immunologists
  • It focuses on helping people with HIV stay healthy and live longer, healthier lives.
  • HIV stigma and promoting HIV testing, prevention, and treatment.
  • HIV Prevention encourages health care providers to prescribe pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) to prevent new HIV infections.

Session and Tracks

Track 01-AIDS stigma and discrimination:-

HIV stigma and separation can posture multifaceted obstacles to restraint, testing, treatment, and upkeep for individuals existing with or at chance for HIV. A few outlines of shame prohibit being avoided by household, nobles, and the more extensive community; getting destitute treatment in wellbeing care and encountering basic self-assuredness, insuperable, or irritating. A few substances with HIV have been denied or misplaced business, lodging, and other administrations avoided from accepting wellbeing care. Denied get to to instructive and preparing programs and have been casualties of savagery and despise wrongdoings. HIV-related disgrace and segregation anticipates people from learning their HIV status, illuminating their status indeed to family partners and sexual accomplices and getting to restorative care and treatment, debilitating their capability to secure themselves from getting or transmitting HIV, and to remain sound. HIV-related shame is made more complex when people moreover association disgrace related to substance utilize mental wellbeing, sexual introduction, sex character, race/civilization, or sex work.

Track 02-Viral, Bacterial, Fungal & Protozoan STDs:-

Viral STDs are caused by infections passed from person-to-person and dependent on the STD, can be transmitted amid sexual movement, amid non-sexual contact with extra person, from mother to newborn child amid pregnancy, birth, or breastfeeding, blood transfusions or dissemination. Medicate hardware and in a few cases, from shower towel, straws or other objects that come in interaction with a tainted person. Viral STDs incorporate Cytomegalovirus, Genital Warts / Human Papillomavirus (HPV), Hepatitis (A, B, &C), Herpes (HSV1 & HSV2), HIV (Helps), Molluscum Contagiosum, Mononucleosis (‘Mono’) etc. Bacterial STDs are caused by microbes drived from person-to-person through sexual movement. STDs caused by microscopic organisms incorporate, Chlamydia (Chlamydia trachomatis) Gonorrhoea (Neisseria gonorrhoea) Granuloma inguinale (Calymmatobacterium granulomatis) chanchroid etc.

Track 03-Lived experience of HIV:-

 HIV is presently measured a inveterate, instead of deadly, malady. Specialists recognize much more almost overseeing HIV than they did 30 a long time prior. But patients living with HIV still confront various errands. A few of these are tireless issues, for case, patients may still confront separation due to confusions around how HIV is transmitted. People who have psychiatric circumstances or who manhandle drugs or liquor are still the slightest likely to watch to treatment. Nowadays, Emphatically Living & Amazing Wellbeing Arrange works as non-profit organization serving East Tennessee’s most exposed populaces, about 5,000 individuals and families battling to outlive the challenges made by HIV, vagrancy, mental sickness, substance utilize, and incapacities.

Track 04- HIV and AIDS Nursing Care Management:-

 Medical caretakers have a noteworthy caring part for patients with HIV, from giving data and bolster some time recently determination, through to giving counsel concerning treatment and common wellbeing issues Medical caretakers regularly have more time than specialists to talk about issues with people and may be way better able to clarify what the specialist has said in a dialect the quiet will recognize. Patients who call THT for counsel are now and then insensible that medical attendants can give this level of offer assistance. For the most part, patients are exceptionally fulfilled with bolster from medical attendants and report disclosure it simpler to conversation to medical attendants. Medical caretakers are moreover repetitively included in HIV testing, empowering and encouraging choices on whether to test, taking blood tests, and giving exhortation and data for individuals who test HIV positive.

Track 05 -Pediatric HIV AIDS:-

More than 90% of HIV infections in children are caused by mother-to-child transmission, which occurs when an HIV-positive mother passes the virus on to her infant during the perinatal period, childbearing, or breastfeeding. The likelihood of this type of transmission increases in direct proportion to the severity of the mother's HIV infection. Broods living with HIV are wiped off more mercilessly than adults because their safe frameworks are not fully developed. They may be exposed to the same common paediatric infections as HIV-negative youngsters, but they will not be able to fight them as effectively. Ear and sinus infections, sepsis, pneumonias, TB, urinary tract infections, duodenal illness, skin illness, and meningitis are all common infections among HIV-positive youngsters. Tuberculosis, the runs, and respiratory illnesses are frequent in HIV-positive children in developing countries. 

Track 06 -HIV and Retroviral Diseases:-

A retrovirus is a type of virus that belongs to the Retroviridae family that transmits its genetic blueprint in the form of ribonucleic acid (RNA).  Retroviruses are called after the reverse transcriptase enzyme, which was discovered by American virologists Howard Temin and David Baltimore in 1971. Reverse transcriptase is a protein that converts RNA to deoxyribonucleic acid (DNA), reversing the usual direction of cellular transcription (DNA into RNA)  Because of the operation of reverse transcriptase, genetic material from a retrovirus has the potential to become permanently integrated into the DNA genome of an infected cell. In the biological sciences, the enzyme is widely employed to combine genes. Human immunodeficiency virus (HIV) is a retrovirus that causes acquired immunodeficiency syndrome (AIDS) in humans. Simian immunodeficiency virus (SIV), a retrovirus prevalent in chimps and gorillas, is closely linked to HIV.

Track 07- HIV Drug Discovery and Research:-

 The initial efficiency of combinatorial antiretroviral therapy in the treatment of HIV infection has been co-operated to some extent by rapid growth of multidrug-resistant HIV strains, poor bioavailability, and accumulative toxicities, and so there is a need for alternative strategies of antiretroviral drug discovery and additional therapeutic agents with novel action methods or targets. From this perception, we first review recent strategies of antiretroviral drug discovery and optimization, with the aid of selected examples from the recent literature. We highlight the expansion of phosphate ester-based prodrugs as means to improve the aqueous solubility of HIV inhibitors, and the introduction of the substrate envelope hypothesis as a new approach for overcoming HIV drug resistance. Lastly, we discuss future guidelines for research, including opportunities for exploitation of novel antiretroviral targets, and the approach of activation of latent HIV reservoirs as a means to exterminate the virus.

Track 08 -HIV/AIDS Nursing and AIDS awareness:-

 HIV can be diffused through blood transfusion while 97 per cent of them knew that it could transfer through unsterilized needles and syringes. Mutual misconceptions among the defendants about HIV/AIDS were HIV transmission through hugging, sharing toilet seats, towels, tackles, shaking hands and even mosquito-bites. Out of the total 95 nursing students who perceived that by altering behaviour one could avoid getting AIDS, 60 per cent of them measured it important to be faithful to one’s life partner. 70 per cent of them knew that blood transfusion related infection can be reduced by getting screened blood. More than 60 per cent of the students discoursed that TV is the best mode to instruct awareness to the communal followed by posters, radio etc.

Track 09 -Venereal Diseases Prevention and Treatment:-


 Several sociocultural factors, including as culture, age, employment, education, religion, and gender, influence how people participate in avoiding the spread of STDs. These factors can influence sexual behaviour and, as a result, the transmission of viruses. • Do not have sex until you have seen a consultant and have been treated. · Follow your doctor's treatment recommendations. • Always use condoms when having sex, especially with new partners. • If your doctor thinks it's okay, don't start having sex again. • Visit your doctor again to get rechecked. • Make certain that your sex partner or partners are also treated.


Antibiotics can be used to treat STDs caused by bacteria or parasites. Although there is no cure for STDs caused by viruses, medications can assist with symptoms and reduce your risk of spreading the infection. The chance of transmitting or spreading STDs is considerably reduced, but not fully eliminated, when latex condoms are used correctly. Not having anal, vaginal, or oral intercourse is the most reliable strategy to avoid infection.

Track 10- HIV and cardiovascular disease:-

The event of unremitting illness complications in controlled HIV illness has changed the scene of HIV clinical care. HIV disease confers a moved forward cardiovascular malady chance which is thought to be due to a complex interaction of programmed variables. Whereas conventional cardiovascular hazard components likely play a part, later prove proposes that HIV-associated irritation and safe enactment are critical go between of cardiovascular chance. It is vague whether built up preventative interferer for the common populace are pertinent to HIV-infected patients, and the got to decipher unthinking information into HIV-specific clinical mediations speaks to a critical need. Created methodologies to avoid cardiovascular illness in HIV-infected person’s calls for a multidisciplinary approach and speaks to an opportunity to apply a major open wellbeing affect in an at-risk population

Track 11- HIV and bone damage:-

Bones have slanted to urge weaker as you get more seasoned. This will be overwhelmingly genuine on the off chance that you have got the human immunodeficiency infection (HIV). The infection, which causes Helps, itself, may make your bones more conceivable to break. And a few anti-HIV medicines may raise your chances for bone loss. Over time, that can cause your bones to change over delicate. In case you lose as well much bone mass, or thickness, your specialist may identify you with osteoporosis. A slighter level of bone misfortune is called osteopenia. Near half of all people with HIV will get osteoporosis or osteopenia. They are too at slightest twice as conceivable to break a bone as those who don’t have the infection. Numerous things may play a part in raising the hazard of moo bone thickness and fractures.

Track 12 -HIV and Aging:-

 Individuals maturing with HIV share numerous of the same wellbeing concerns as the common populace matured 50 and more seasoned:- numerous inveterate maladies or conditions, utilize the numerous solutions, changes in physical and cognitive capacities, and expanded defencelessness to stressors. In expansion, whereas viable HIV treatment has diminished the probability of AIDS-defining ailments among individuals maturing with HIV, numerous HIV-associated non-AIDS conditions happen regularly in more seasoned people with HIV, such as cardiovascular infection, diabetes, renal infection, and cancer. These conditions are likely related to a number of collaboration variables, counting inveterate irritation caused by HIV. Analysts are working to way better get it what causes inveterate aggravation, indeed when individuals are being treated with ART.

Track 13 -HIV in women:-

The foremost common way in ladies get HIV is through sex with a male accomplice who has HIV without employing a condom. HIV is spread through the blood, pre-seminal liquids, semen, vaginal liquids, rectal liquids, and breast milk. Having butt-centric or vaginal sex with a individual who has HIV without employing a condom or taking drugs to avoid or treat HIV. Butt-centric sex is the perilous sort of sex for getting HIV, since the rectum’s lining is lean and may permit HIV to enter the body amid butt-centric sex. Sharing infusions and medicate equipment’s such as needles, with a individual who has HIV.

Track 14- HIV Diagnosis and Therapy:-

The most prevalent method for diagnosing HIV is through blood tests. These tests check for antibodies to the virus that the body produces in an attempt to combat the infection. People who have been exposed to the virus must be tested very away, even though antibodies to the virus might take anywhere from six weeks to a year to develop in the body. It is vital to conduct early testing. If you test positive for HIV, you and your doctor will talk about it and come up with a treatment plan to help you fight the virus. Initial testing might also warn you about high-risk behaviours that could spread the infection to others. The majority of health-care workers provide HIV testing, which is frequently accompanied by adequate counselling. Testing is also accessible in an anonymous and cost-free format. Following the completion of tests, your doctor will inquire about your symptoms, medical history, and risk factors, as well as conduct a physical examination.

Track 15- Emerging Technologies towards HIV/AIDS:-

In the last ten years, the subject of technology-enabled HIV research and prevention has emerged as a vibrant, dynamic sector with enormous promise to assist bring HIV preventive initiatives to high-risk populations. Expansions in technology and HIV epidemics both point to new approaches to reach the most vulnerable groups. Interferences and services currently provided by people cannot be completely replaced by new technologies. However, we believe that emerging technologies have the ability to scale services and provide efficiencies in reaching rural MSM communities, engaging with people who aren't being reached by current metropolitan outreach initiatives, and offering algorithmically specified services or research projects.

Track 16 -HIV & Vaccines:-

Over the last 30 years, HIV treatment choices have vastly improved. However, medications can have negative side effects, be expensive, and be difficult to obtain in some countries. Some people may acquire drug resistance to particular HIV treatments, requiring them to switch regimens. HIV transmission can be prevented by properly using condoms and taking pre-exposure prophylaxis. However, researchers believe that the most efficient strategy to fully eliminate new HIV infections is to develop a prophylactic HIV vaccine. 1.    Covid-19 2. Hepatitis B is the second most common kind of hepatitis. 3. Human papillomavirus (for those up to age 26) 4 Influenza Virus (flu) 5 meningococcal vaccines to prevent meningococcal illness 6 pneumococcal infections (pneumonia) 7 Pertussis, tetanus, and diphtheria (whooping cough).  The three illnesses are all protected by a single vaccine.

Track 17- Viral Immunology and Vaccines development:-

Vaccines are one of the most significant triumphs of modern medicine. Recent advances in innate immunity have brought new insights into the mechanisms of vaccine-induced resistance, allowing for a more rational vaccine design approach. Viruses are responsible for a wide range of human diseases, from common ailments like the flu to new infections. Anyone interested in developing or disseminating vaccines to combat these diseases must first comprehend how the immune system prevents and eliminates viral infections.

Track 18 -Awareness and knowledge on HIV/AIDS, STDs and STIs:-

The human immunodeficiency virus (HIV) has emerged as the most difficult public health and human rights concern. One of the primary tactics used in the prevention and control of HIV/AIDS around the world is spreading knowledge and awareness about the virus. Inadequate information and unsafe practices are important obstacles to avoiding HIV transmission. Sexually transmitted infections (STDs) and unintended pregnancies are common among adolescents in many countries. By the age of 15, a significant proportion of young people in many countries have begun sexual activity. Adolescents are thus at a higher risk of catching HIV through sexual transmission in general. More than one in every five new diagnoses was made by children aged 13–14.

Market Analysis

       The fact that HIV infection and AIDS have become a major global public health problem is now accepted. The significance, risk, and expense of HIV/AIDS cannot be overstated or minimised. While we are fortunate that, at least for The United States and Europe,  the apocalyptic predictions of the mid-1980s have not come to pass. HIV/AIDS continues to have a huge impact on global society.

While HIV/AIDS does not make the news as frequently as it did when it was first discovered, more people in the United States are living with the disease than ever before. While the prevalence of HIV infection in the United States was around 0.25 percent of the population ten to fifteen years ago, it is currently at 0.47 percent, and the population has expanded in general.

As a result, it's critical to comprehend HIV/AIDS epidemic patterns and their possible consequences for economies and communities.

HIV Diagnosis Market analysis:

From USD 2.35 billion in 2016, the HIV diagnostic market is expected to grow at a CAGR of 10.5 percent to USD 3.88 billion by 2021. The market is predicted to develop due to factors such as the rising global prevalence of HIV/AIDS, the rising number of blood transfusions and blood donations, the benefits provided by point-of-care tools and kits, and increased government initiatives. The study's base year was 2015, and the projection was made for the years 2016 through 2021.

Significant Market Changes:

• Siemens introduced a software update for the RAPID Comm Data Management System in March 2014, a system for centrally managing Siemens' In Vitro Diagnostics analysers and operators at the point-of-care.

• Siemens Healthineers spent $300 million in its Walpole, Massachusetts factory in December 2016 to manufacture the ADVIA Centaur series of immunoassay devices.

• In June 2016, Roche announced a new product.


Benefits of Participation

Benefits of Participation for Speaker

  • Worldwide appreciation of the profile of Researchers.
  • Obtain credits for professional growth.
  • Explore the latest of cutting edge analysis.
  • Make long-term bonds at social and networking activities.
  • An ability to advertise one page in the distribution of abstract books and flyers that ultimately gets 1 million views and adds great value to your research profile.
  • Learn a transition beyond your area of interest to learn more about new subjects and studies away from your core subject of Drug discovery of HIV.
  • We have distinctive networking, learning and enjoyable integration into a single package.

Benefits of Participation for Delegate

  • Professional Development-Improve understanding and knowledge.
  • Attendance at webinar supports rejuvenates and energises delegates.
  • Your involvement in our webinar will help with a new methodology and ideology that can be used to broaden the outcomes of businesses or industries.
  • Opportunities for Global Summit researchers and experts in the same field to meet and exchange new ideas through Webinar.

Benefit of Participation for Sponsor

  • Exposure to the international environment would increase the possibility of new companies.
  • Opportunity to demonstrate your company's latest technologies, new products, or service your business to a wide range of international participants.
  • Increase business by our webinar participants through lead generation.
  • It takes a lot of time, effort and drive to create a successful company, so it's always nice to have a network of colleagues and associates to draw energy from individuals who share a common drive and objective.
  • Webinar in HIV/AIDS provide opportunities for more attention and contemplation that could help you move your company to the next stage.
  • Benchmarking main organization plans and moving it forward.
  • Get feedback from trustworthy people at our webinar to your company questions and challenges.
  • On our webinar banner, website and other proceedings, branding and marketing content, the advertising logo of your company.

Benefit of Association for Collaborators

  • Nobody has these massive visitors to HIV AIDS and STDS webinar in the world; this is the best forum to highlight society.
  • Creating long-lasting peer relationships.
  • In our webinar banner, website and other proceedings, branding and marketing material, promotional content and your Organization logo will increase your number of subscribers/members by 40%.
  • The exposure of our event to your Company listing in the Global Business forum will have a great effect on your association.
  • Your representatives can network to update their knowledge and understanding of your organisation and services with key webinar delegates.
  • HIV Infection advertising materials such as posters, brochures, pamphlets, services that will be circulated to hospitals, universities, society and researchers will be integrated with information.


To Collaborate Scientific Professionals around the World

Conference Date April 28-29, 2022

For Sponsors & Exhibitors

Speaker Opportunity

Supported By

HIV: Current Research

All accepted abstracts will be published in respective Conference Series International Journals.

Abstracts will be provided with Digital Object Identifier by

Media partners & Collaborators & Sponsors


Media Partner


Media Partner


Media Partner


Media Partner


  • AIDS Stigma And Discrimination
  • Antiretroviral Drugs (ARVs)
  • Antiretroviral Treatment (ART)
  • Awareness And Knowledge On HIV/AIDS, STDs And STIs
  • Bacterial Infections
  • CD4 Count
  • Chronic HIV
  • Clinical Latency
  • Co-infection
  • Complementary Therapies
  • Drug Interactions
  • Drug Resistant Strains
  • Emerging Technologies Towards HIV/AIDS
  • Fungal Infections
  • Generic Drugs
  • Health Issues In Aging HIV
  • HIV & Vaccines
  • HIV And Aging
  • HIV And AIDS Nursing Care Management
  • HIV And Bone Damage
  • HIV And Cardiovascular Disease
  • HIV And Retroviral Diseases
  • HIV Criminalization
  • HIV Diagnosis And Therapy
  • HIV Drug Chart (Overview)
  • HIV Drug Discovery And Research
  • HIV In Women
  • HIV Infection
  • HIV Latency
  • HIV Treatment As Prevention (TasP)
  • HIV/AIDS Nursing And AIDS Awareness
  • Lived Experience Of HIV
  • MSM
  • Opportunistic Infections
  • Pediatric HIV AIDS
  • Perinatal Transmission
  • Screening For HIV Infection
  • Seroconversion
  • Sexual And Reproductive Health
  • Sexually Transmitted Diseases
  • Stigma
  • Transmitted Resistance
  • Vaccination Therapy
  • Vaccines Development
  • Venereal Diseases Prevention And Treatment
  • Viral Immunology
  • Viral Infections
  • Viral Suppression
  • Western Blot Test